Nuveen Asset Management’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $241K | Buy |
79,101
+23,179
| +41% | +$70.7K | ﹤0.01% | 3172 |
|
|
2024
Q3 | $143K | Hold |
55,922
| – | – | ﹤0.01% | 3276 |
|
|
2024
Q2 | $182K | Buy |
+55,922
| New | +$182K | ﹤0.01% | 3234 |
|
|
2022
Q2 | – | Sell |
-99,587
| Closed | -$308K | – | 3359 |
|
|
2022
Q1 | $308K | Buy |
99,587
+26
| +0% | +$80 | ﹤0.01% | 3120 |
|
|
2021
Q4 | $283K | Sell |
99,561
-9,708
| -9% | -$27.6K | ﹤0.01% | 3184 |
|
|
2021
Q3 | $754K | Sell |
109,269
-2,135
| -2% | -$14.7K | ﹤0.01% | 3083 |
|
|
2021
Q2 | $1.02M | Sell |
111,404
-132,963
| -54% | -$1.22M | ﹤0.01% | 2995 |
|
|
2021
Q1 | $2.38M | Buy |
244,367
+102,917
| +73% | +$1M | ﹤0.01% | 2541 |
|
|
2020
Q4 | $1.45M | Buy |
141,450
+267
| +0.2% | +$2.74K | ﹤0.01% | 2662 |
|
|
2020
Q3 | $1.42M | Sell |
141,183
-309,957
| -69% | -$3.13M | ﹤0.01% | 2519 |
|
|
2020
Q2 | $4.71M | Sell |
451,140
-28,388
| -6% | -$296K | ﹤0.01% | 1927 |
|
|
2020
Q1 | $4.05M | Sell |
479,528
-800,760
| -63% | -$6.76M | ﹤0.01% | 1839 |
|
|
2019
Q4 | $11.2M | Buy |
1,280,288
+118,047
| +10% | +$1.03M | ﹤0.01% | 1520 |
|
|
2019
Q3 | $12.5M | Buy |
1,162,241
+555,116
| +91% | +$5.98M | 0.01% | 1422 |
|
|
2019
Q2 | $7.72M | Buy |
+607,125
| New | +$7.72M | ﹤0.01% | 1757 |
|
|
2015
Q2 | – | Sell |
-10,639
| Closed | -$2.51M | – | 1531 |
|
|
2015
Q1 | $2.51M | Buy |
10,639
+1,445
| +16% | +$341K | 0.01% | 730 |
|
|
2014
Q4 | $1.74M | Buy |
9,194
+227
| +3% | +$43K | 0.01% | 862 |
|
|
2014
Q3 | $2.14M | Buy |
+8,967
| New | +$2.14M | 0.01% | 753 |
|
|
2014
Q2 | – | Sell |
-15,126
| Closed | -$1.58M | – | 1576 |
|
|
2014
Q1 | $1.58M | Buy |
15,126
+10,471
| +225% | +$1.09M | 0.01% | 865 |
|
|
2013
Q4 | $482K | Buy |
+4,655
| New | +$482K | ﹤0.01% | 1254 |
|